These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19430912)

  • 1. Peptide kappa opioid receptor ligands: potential for drug development.
    Aldrich JV; McLaughlin JP
    AAPS J; 2009 Jun; 11(2):312-22. PubMed ID: 19430912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands.
    Spetea M; Schmidhammer H
    Handb Exp Pharmacol; 2022; 271():163-195. PubMed ID: 33454858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses.
    Dunn AD; Reed B; Erazo J; Ben-Ezra A; Kreek MJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3590-3600. PubMed ID: 31313902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
    Bidlack JM
    Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples.
    Muratspahić E; White AM; Ciotu CI; Hochrainer N; Tomašević N; Koehbach J; Lewis RJ; Spetea M; Fischer MJM; Craik DJ; Gruber CW
    J Med Chem; 2023 Sep; 66(17):11843-11854. PubMed ID: 37632447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development.
    Aldrich JV; McLaughlin JP
    Handb Exp Pharmacol; 2022; 271():197-220. PubMed ID: 34463847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S; Aldrich JV; Walker BM
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.
    Ko MC; Husbands SM
    Handb Exp Pharmacol; 2022; 271():435-452. PubMed ID: 33274403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA; Murray TF; Aldrich JV
    J Med Chem; 2015 Nov; 58(22):8783-95. PubMed ID: 26491810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine upregulates kappa-opioid receptors of human lymphocytes.
    Suzuki S; Chuang TK; Chuang LF; Doi RH; Chuang RY
    Adv Exp Med Biol; 2001; 493():81-7. PubMed ID: 11727785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):378-85. PubMed ID: 10087027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opioid ligands in the study and treatment of mood disorders.
    Carlezon WA; Béguin C; Knoll AT; Cohen BM
    Pharmacol Ther; 2009 Sep; 123(3):334-43. PubMed ID: 19497337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
    Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
    Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening.
    Spetea M; Asim MF; Noha S; Wolber G; Schmidhammer H
    Curr Pharm Des; 2013; 19(42):7362-72. PubMed ID: 23448472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia.
    Deuis JR; Whately E; Brust A; Inserra MC; Asvadi NH; Lewis RJ; Alewood PF; Cabot PJ; Vetter I
    ACS Chem Neurosci; 2015 Oct; 6(10):1751-8. PubMed ID: 26225903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.